AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

NORTH CHICAGO, Ill. and ROCKVILLE, Md., Jan. 13, 2025 /PRNewswire/…

Read More
Novavax is Powering the Future of Vaccines Through R&D and Value-creating Business Strategy

Novavax is Powering the Future of Vaccines Through R&D and Value-creating Business Strategy

January 13, 2025 - By Ruxandra Draghia-Akli,…

Read More
VEDP: Booming Virginia clusters provide a supply chain blueprint for increasing drug accessibility, affordability

VEDP: Booming Virginia clusters provide a supply chain blueprint for increasing drug accessibility, affordability

Like his fellow Type 1 diabetics,…

Read More
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

GAITHERSBURG, Md., Jan. 13, 2025 (GLOBE NEWSWIRE) --…

Read More
The Baltimore Banner: University of Maryland merges engineering and medicine to turn ideas into companies

The Baltimore Banner: University of Maryland merges engineering and medicine to turn ideas into companies

It’s Baltimore’s latest move toward becoming…

Read More
ARPA-H RAPID Program: Rare Disease AI/ML for Precision Integrated Diagnostics

ARPA-H RAPID Program: Rare Disease AI/ML for Precision Integrated Diagnostics

*NOTE: Solution Summary due: February 14,…

Read More
Veralox Therapeutics Expands Its Pipeline with the Exclusive Option to Acquire Nudge Therapeutics

Veralox Therapeutics Expands Its Pipeline with the Exclusive Option to Acquire Nudge Therapeutics

FREDERICK, Md., Jan. 9, 2025 /PRNewswire/ -- Veralox…

Read More
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care

GERMANTOWN, Md., & VENLO, The Netherlands--(BUSINESS…

Read More
NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

BELTSVILLE, Md., Jan. 10, 2025 (GLOBE…

Read More
Montgomery County Economic Development Corporation President and CEO Bill Tompkins Plans to Step Down at the End of His Current Term

Montgomery County Economic Development Corporation President and CEO Bill Tompkins Plans to Step Down at the End of His Current Term

Montgomery County, MD — The Montgomery…

Read More
Emmes Group Company, Essex Management Appoints David Loose as Chief Executive Officer

Emmes Group Company, Essex Management Appoints David Loose as Chief Executive Officer

ROCKVILLE, Md., Jan. 7, 2025 /PRNewswire/ -- Essex Management,…

Read More
Why the DMV Region Is Thriving as a Hub for Startups and Innovation

Why the DMV Region Is Thriving as a Hub for Startups and Innovation

The Washington D.C., Maryland, and Virginia…

Read More
Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax®

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax®

GAITHERSBURG, Md., Jan. 08, 2025 (GLOBE…

Read More
IonQ Completes Acquisition of Qubitekk, Solidifying Leadership in Quantum Networking

IonQ Completes Acquisition of Qubitekk, Solidifying Leadership in Quantum Networking

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ (NYSE: IONQ),…

Read More
I-Mab Focuses on Advancing Givastomig as Lead Cancer Therapy in Clinical Development

I-Mab Focuses on Advancing Givastomig as Lead Cancer Therapy in Clinical Development

ROCKVILLE, MD, Jan. 6, 2025 /PRNewswire/ -- I-Mab…

Read More